About Us

The MICROBRADAM Consortium was started in 2015 and is involved in the development of innovatve MR methods.

Social Media

The MICROBRADAM collaboration, thanks to the grant awarded as a part of the Marie Skłodowska-Curie actions under Horizon 2020, has developed a multimodal approach for the early diagnosys of Parkinson Disease based on MRI images.

"We still lack an effective treatment for Parkinson's Disease, however our new approach has the potential to identify the early damages to tissue caused by pathology, thus helping an earlier diagnosys and - in perspective -  the assessment of new treatments", declared Federico Giove, coordinator of the European project.

The MICROBRADAM partnership includes institution and scientists from Finland, Czech Republic, Italy and USA, and aims to transfer the newly developed technologies to the clinical practice.

Idiopathic rapid eye movement sleep behavior disorder (iRBD) is a condition that often evolves into Parkinson's disease (PD). Therefore, by monitoring iRBD it is possible to track the neurodegeneration of individuals who may progress to PD. Here we aimed at piloting the characterization of brain tissue properties in mid-brain subcortical regions of 10 healthy subjects, 8 iRBD, and 9 early-diagnosed PD.

AD semantic figure

We used a battery of magnetic resonance imaging (MRI) contrasts at 3 T, including adiabatic and non-adiabatic rotating frame techniques developed by our group, along with diffusion tensor imaging (DTI) and resting-state fMRI. Adiabatic T1ρ and T2ρ, and non-adiabatic RAFF4 (Relaxation Along a Fictitious Field in the rotating frame of rank 4) were found to have lower coefficient of variations and higher sensitivity to detect group differences as compared to DTI parameters such as fractional anisotropy and mean diffusivity. Significantly longer T1ρ were observed in the amygdala of PD subjects vs. controls, along with a trend of lower functional connectivity as measured by regional homogeneity, thereby supporting the notion that amygdalar dysfunction occurs in PD. Significant abnormalities in reward networks occurred in iRBD subjects, who manifested lower network strength of the accumbens. In agreement with previous studies, significantly longer T1ρ occurred in the substantia nigra compacta of PD vs. controls, indicative of neuronal degeneration, while regional homogeneity was lower in the substantia nigra reticulata. Finally, other trend-level findings were observed, i.e., lower RAFF4 and T2ρ in the midbrain of iRBD subjects vs. controls, possibly indicating changes in non-motor features as opposed to motor function in the iRBD group. We conclude that rotating frame relaxation methods along with functional connectivity measures are valuable to characterize iRBD and PD subjects, and with proper validation in larger cohorts may provide pathological signatures of iRBD and PD.

Download here the full paper.